E. coli caused immunohistochemical changes and neurobehavioral dysfunction.
Dexamethazone provides neuroprotection against E. coli-associated sickness behavior.
The inhibition of inflammatory response was achieved through the reduction of IFNγ level.
The expression of caspase-3 was suppressed, suggesting the inhibition of apoptosis by DEX.